Company / Working Capital
Eledon Pharmaceuticals, Inc. Working Capital History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$26.7M
FY2016
5-year range
$26.7M / $103.3M
FY2014-FY2016
Trend
-56.2%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $103M to $27M over the past 2 years.
Based on SEC 10-K filings.
$27M in FY2016.
Declined from $103M to $27M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, working capital decreased 56.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $26.7M | -56.2% |
| FY2015 | $61.0M | -40.9% |
| FY2014 | $103.3M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026